MicroRNA-503 promotes tumor progression and acts as a novel biomarker for prognosis in esophageal cancer

被引：0
|
作者：
Mori, Koichiro [1 ]
Toiyama, Yuji [1 ]
Ide, Shozo [1 ]
Noguchi, Tomofumi [1 ]
Imaoka, Hiroki [1 ]
Yasuda, Hiromi [1 ]
Saigusa, Susumu [1 ]
Ohi, Masaki [1 ]
Inoue, Yasuhiro [1 ]
Tanaka, Koji [1 ]
Mohri, Yasuhiko [1 ]
Nobori, Tsutomu [1 ]
Kusunoki, Masato [1 ]
机构：
[1] Mie Univ, Tsu, Mie 514, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3401
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer
    Chuan Liu
    Xiaowei Fu
    Zhiwei Zhong
    Jing Zhang
    Haiyan Mou
    Qiong Wu
    Tianle Sheng
    Bo Huang
    Yeqing Zou
    Digestive Diseases and Sciences, 2017, 62 : 2376 - 2385
  • [22] CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer
    Liu, Chuan
    Fu, Xiaowei
    Zhong, Zhiwei
    Zhang, Jing
    Mou, Haiyan
    Wu, Qiong
    Sheng, Tianle
    Huang, Bo
    Zou, Yeqing
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (09) : 2376 - 2385
  • [23] Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer
    Ma, Gang
    Dai, Weijie
    Sang, Aiyu
    Yang, Xiaozhong
    Gao, Chengcheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (12): : 8833 - 8840
  • [24] RETRACTION: MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM (Retraction of Vol 9, art no E114585, 2014)
    Chong, Y.
    PLOS ONE, 2022, 17 (06):
  • [25] MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
    Gu, Jian
    Wang, Yan
    Wu, Xifeng
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (07) : 1292 - 1300
  • [26] MicroRNA-101 is a novel biomarker for diagnosis and prognosis in breast cancer
    Wei, Na
    Ni, Qing
    Dai, Min
    Wang, Shu
    Liu, Xin
    Wang, Hua
    Hou, Jing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (03): : 3279 - 3285
  • [27] CARMIL3 promotes tumor progression in triple negative breast cancer: A possible novel biomarker
    Lee, Jeeyeon
    Baek, Dong Won
    Lee, Soo Jung
    Jeong, Jae-Hwan
    Lee, In Hee
    Jung, Jin Hyang
    Park, Ho Yong
    Chae, Yee Soo
    Kang, Jieun
    CANCER RESEARCH, 2019, 79 (13)
  • [28] SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma
    Kong, Pengzhou
    Jiao, Ye
    Sun, Meng
    Zhou, Zhinan
    Zhang, Yingying
    Yang, Xin
    Ren, Jing
    Yang, Mengyuan
    Dong, Yanyan
    Song, Bin
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [29] The microRNA-424/503 cluster: A master regulator of tumorigenesis and tumor progression with paradoxical roles in cancer
    Wu, Ye
    Wang, Wei
    Yang, An-Gang
    Zhang, Rui
    CANCER LETTERS, 2020, 494 : 58 - 72
  • [30] GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer
    Cheng, Yongbiao
    Xu, Tianbo
    Li, Sen
    Ruan, Hailong
    AGING-US, 2019, 11 (24): : 12165 - 12176
12345